Jiangsu Hengrui Medicine
600276.SS
#494
Rank
C$58.10 B
Marketcap
$9.11
Share price
-0.62%
Change (1 day)
9.88%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total assets

Total assets on the balance sheet as of September 2024 : C$9.90 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total assets are C$9.90 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Jiangsu Hengrui Medicine - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2022-12-31C$8.33 B6.11%
2021-12-31C$7.85 B15.67%
2020-12-31C$6.78 B31.78%
2019-12-31C$5.15 B15.54%
2018-12-31C$4.45 B27.91%
2017-12-31C$3.48 B25.7%
2016-12-31C$2.77 B12.71%
2015-12-31C$2.46 B44.49%
2014-12-31C$1.70 B34.09%
2013-12-31C$1.27 B35.14%
2012-12-31C$0.93 B20.52%
2011-12-31C$0.77 B32.41%
2010-12-31C$0.58 B27.48%
2009-12-31C$0.46 B14.83%
2008-12-31C$0.40 B42.94%
2007-12-31C$0.28 B28.5%
2006-12-31C$0.21 B18.1%
2005-12-31C$0.18 B1.67%
2004-12-31C$0.18 B-19.87%
2003-12-31C$0.22 B-0.97%
2002-12-31C$0.22 B6.72%
2001-12-31C$0.21 B